# CrowdStrike Holdings, Inc.: financial statements, quarterly

CRWD · Nasdaq · CIK 1535527 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/crwd.md) · [Financials](/companies/crwd/financials.md) · [Filings](/companies/crwd/filings.md) · [Insiders](/companies/crwd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crwd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [786](/filings/0001535527-24-000026.md) | [845 d](/filings/0001535527-26-000010.md) | [921](/filings/0001535527-25-000019.md) | [964](/filings/0001535527-25-000025.md) | [1,010](/filings/0001535527-25-000033.md) | [1,059 d](/filings/0001535527-26-000010.md) | [1,103](/filings/0001535527-26-000025.md) | [1,169](/filings/0001535527-26-000031.md) | [1,234](/filings/0001535527-25-000033.md) | [1,305 d](/filings/0001535527-26-000010.md) | [1,386](/filings/0001535527-26-000025.md) | [1,471](/filings/0001535527-26-000031.md) |
| Cost of revenue | $m | [195](/filings/0001535527-24-000026.md) | [212 d](/filings/0001535527-26-000010.md) | [225](/filings/0001535527-25-000019.md) | [237](/filings/0001535527-25-000025.md) | [255](/filings/0001535527-25-000033.md) | [273 d](/filings/0001535527-26-000010.md) | [288](/filings/0001535527-26-000025.md) | [309](/filings/0001535527-26-000031.md) | [308](/filings/0001535527-25-000033.md) | [312 d](/filings/0001535527-26-000010.md) | [342](/filings/0001535527-26-000025.md) | [374](/filings/0001535527-26-000031.md) |
| Gross profit | $m | [591](/filings/0001535527-24-000026.md) | [634 d](/filings/0001535527-26-000010.md) | [696](/filings/0001535527-25-000019.md) | [726](/filings/0001535527-25-000025.md) | [755](/filings/0001535527-25-000033.md) | [786 d](/filings/0001535527-26-000010.md) | [816](/filings/0001535527-26-000025.md) | [860](/filings/0001535527-26-000031.md) | [926](/filings/0001535527-25-000033.md) | [994 d](/filings/0001535527-26-000010.md) | [1,043](/filings/0001535527-26-000025.md) | [1,097](/filings/0001535527-26-000031.md) |
| Research and development | $m | [196](/filings/0001535527-24-000026.md) | [226 d](/filings/0001535527-26-000010.md) | [235](/filings/0001535527-25-000019.md) | [251](/filings/0001535527-25-000025.md) | [276](/filings/0001535527-25-000033.md) | [314 d](/filings/0001535527-26-000010.md) | [331](/filings/0001535527-26-000025.md) | [343](/filings/0001535527-26-000031.md) | [348](/filings/0001535527-25-000033.md) | [356 d](/filings/0001535527-26-000010.md) | [408](/filings/0001535527-26-000025.md) | [444](/filings/0001535527-26-000031.md) |
| Operating income | $m | [3.2](/filings/0001535527-24-000026.md) | [12.5 d](/filings/0001535527-26-000010.md) | [6.9](/filings/0001535527-25-000019.md) | [13.7](/filings/0001535527-25-000025.md) | [(55.7)](/filings/0001535527-25-000033.md) | [(81.3) d](/filings/0001535527-26-000010.md) | [(119)](/filings/0001535527-26-000025.md) | [(105)](/filings/0001535527-26-000031.md) | [(69.4)](/filings/0001535527-25-000033.md) | [13.8 d](/filings/0001535527-26-000010.md) | [(30.6)](/filings/0001535527-26-000025.md) | [(33.2)](/filings/0001535527-26-000031.md) |
| Interest expense | $m | [6.5](/filings/0001535527-23-000026.md) | [6.4 d](/filings/0001535527-24-000007.md) | [6.5](/filings/0001535527-24-000013.md) | [6.5](/filings/0001535527-25-000025.md) | [6.6](/filings/0001535527-25-000033.md) | [6.7 d](/filings/0001535527-26-000010.md) | [6.7](/filings/0001535527-26-000025.md) | [6.8](/filings/0001535527-26-000031.md) | [6.9](/filings/0001535527-25-000033.md) | [7.6 d](/filings/0001535527-26-000010.md) | [6.1](/filings/0001535527-26-000025.md) | [6.0](/filings/0001535527-26-000031.md) |
| Income tax | $m | [9.6](/filings/0001535527-24-000026.md) | [13.6 d](/filings/0001535527-26-000010.md) | [7.7](/filings/0001535527-25-000019.md) | [10.9](/filings/0001535527-25-000025.md) | [6.3](/filings/0001535527-25-000033.md) | [46.3 d](/filings/0001535527-26-000010.md) | [21.1](/filings/0001535527-26-000025.md) | [6.0](/filings/0001535527-26-000031.md) | [10.7](/filings/0001535527-25-000033.md) | [(3.6) d](/filings/0001535527-26-000010.md) | [(6.9)](/filings/0001535527-26-000025.md) | [(1.4)](/filings/0001535527-26-000031.md) |
| Net income | $m | [26.7](/filings/0001535527-24-000026.md) | [36.6 d](/filings/0001535527-26-000010.md) | [42.8](/filings/0001535527-25-000019.md) | [47.0](/filings/0001535527-25-000025.md) | [(16.8)](/filings/0001535527-25-000033.md) | [(88.3) d](/filings/0001535527-26-000010.md) | [(104)](/filings/0001535527-26-000025.md) | [(70.2)](/filings/0001535527-26-000031.md) | [(34.0)](/filings/0001535527-25-000033.md) | [59.4 d](/filings/0001535527-26-000010.md) | [27.8](/filings/0001535527-26-000025.md) | [5.3](/filings/0001535527-26-000031.md) |
| Diluted EPS | $ per share | [0.11](/filings/0001535527-24-000026.md) | not reported | [0.17](/filings/0001535527-25-000019.md) | [0.19](/filings/0001535527-25-000025.md) | [(0.07)](/filings/0001535527-25-000033.md) | not reported | [(0.42)](/filings/0001535527-26-000025.md) | [(0.07)](/filings/0001535527-26-000031.md) | [(0.14)](/filings/0001535527-25-000033.md) | not reported | [0.11](/filings/0001535527-26-000025.md) | [0.01](/filings/0001535527-26-000031.md) |
| Basic EPS | $ per share | [0.11](/filings/0001535527-24-000026.md) | not reported | [0.18](/filings/0001535527-25-000019.md) | [0.19](/filings/0001535527-25-000025.md) | [(0.07)](/filings/0001535527-25-000033.md) | not reported | [(0.42)](/filings/0001535527-26-000025.md) | [(0.07)](/filings/0001535527-26-000031.md) | [(0.14)](/filings/0001535527-25-000033.md) | not reported | [0.11](/filings/0001535527-26-000025.md) | [0.01](/filings/0001535527-26-000031.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.0](/filings/0001535527-24-000026.md) | [3.4](/filings/0001535527-26-000010.md) | [3.7](/filings/0001535527-25-000019.md) | [4.0](/filings/0001535527-25-000025.md) | [4.3](/filings/0001535527-25-000033.md) | [4.3](/filings/0001535527-26-000010.md) | [4.6](/filings/0001535527-26-000025.md) | [5.0](/filings/0001535527-26-000031.md) | [4.8](/filings/0001535527-25-000033.md) | [5.2](/filings/0001535527-26-000031.md) | [4.6](/filings/0001535527-26-000025.md) | [5.0](/filings/0001535527-26-000031.md) |
| Current assets | $bn | [4.1](/filings/0001535527-23-000026.md) | [4.8](/filings/0001535527-25-000009.md) | [4.8](/filings/0001535527-24-000013.md) | [5.2](/filings/0001535527-24-000020.md) | [5.6](/filings/0001535527-24-000026.md) | [6.1](/filings/0001535527-26-000010.md) | [6.1](/filings/0001535527-25-000019.md) | [6.5](/filings/0001535527-25-000025.md) | [6.5](/filings/0001535527-25-000033.md) | [7.4](/filings/0001535527-26-000031.md) | [6.3](/filings/0001535527-26-000025.md) | [7.0](/filings/0001535527-26-000031.md) |
| Total assets | $bn | [5.8](/filings/0001535527-23-000026.md) | [6.6](/filings/0001535527-25-000009.md) | [6.8](/filings/0001535527-24-000013.md) | [7.2](/filings/0001535527-24-000020.md) | [7.8](/filings/0001535527-24-000026.md) | [8.7](/filings/0001535527-26-000010.md) | [8.7](/filings/0001535527-25-000019.md) | [9.3](/filings/0001535527-25-000025.md) | [10.0](/filings/0001535527-25-000033.md) | [11.1](/filings/0001535527-26-000031.md) | [11.3](/filings/0001535527-26-000025.md) | [12.0](/filings/0001535527-26-000031.md) |
| Current liabilities | $bn | [2.4](/filings/0001535527-23-000026.md) | [2.7](/filings/0001535527-25-000009.md) | [2.7](/filings/0001535527-24-000013.md) | [2.7](/filings/0001535527-24-000020.md) | [3.0](/filings/0001535527-24-000026.md) | [3.5](/filings/0001535527-26-000010.md) | [3.3](/filings/0001535527-25-000019.md) | [3.5](/filings/0001535527-25-000025.md) | [3.6](/filings/0001535527-25-000033.md) | [4.2](/filings/0001535527-26-000031.md) | [4.1](/filings/0001535527-26-000025.md) | [4.4](/filings/0001535527-26-000031.md) |
| Total liabilities | $bn | [3.8](/filings/0001535527-23-000026.md) | [4.3](/filings/0001535527-25-000009.md) | [4.3](/filings/0001535527-24-000013.md) | [4.3](/filings/0001535527-24-000020.md) | [4.7](/filings/0001535527-24-000026.md) | [5.4](/filings/0001535527-26-000010.md) | [5.2](/filings/0001535527-25-000019.md) | [5.5](/filings/0001535527-25-000025.md) | [5.9](/filings/0001535527-25-000033.md) | [6.6](/filings/0001535527-26-000031.md) | [6.6](/filings/0001535527-26-000025.md) | [6.9](/filings/0001535527-26-000031.md) |
| Long-term debt | $bn | [0.7](/filings/0001535527-23-000026.md) | [0.7](/filings/0001535527-25-000009.md) | [0.7](/filings/0001535527-24-000013.md) | [0.7](/filings/0001535527-24-000020.md) | [0.7](/filings/0001535527-24-000026.md) | [0.7](/filings/0001535527-26-000010.md) | [0.7](/filings/0001535527-25-000019.md) | [0.7](/filings/0001535527-25-000025.md) | [0.7](/filings/0001535527-25-000033.md) | [0.7](/filings/0001535527-26-000031.md) | [0.7](/filings/0001535527-26-000025.md) | [0.7](/filings/0001535527-26-000031.md) |
| Shareholders' equity | $bn | [2.0](/filings/0001535527-23-000026.md) | [2.3](/filings/0001535527-25-000009.md) | [2.5](/filings/0001535527-24-000013.md) | [2.9](/filings/0001535527-24-000020.md) | [3.1](/filings/0001535527-24-000026.md) | [3.3](/filings/0001535527-26-000010.md) | [3.5](/filings/0001535527-25-000019.md) | [3.8](/filings/0001535527-25-000025.md) | [4.0](/filings/0001535527-25-000033.md) | [4.4](/filings/0001535527-26-000031.md) | [4.6](/filings/0001535527-26-000025.md) | [5.1](/filings/0001535527-26-000031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [274 d](/filings/0001535527-24-000026.md) | [347 d](/filings/0001535527-26-000010.md) | [383](/filings/0001535527-25-000019.md) | [327 d](/filings/0001535527-25-000025.md) | [326 d](/filings/0001535527-25-000033.md) | [346 d](/filings/0001535527-26-000010.md) | [384](/filings/0001535527-26-000025.md) | [333 d](/filings/0001535527-26-000031.md) | [398 d](/filings/0001535527-25-000033.md) | [498 d](/filings/0001535527-26-000010.md) | [591](/filings/0001535527-26-000025.md) | [530 d](/filings/0001535527-26-000031.md) |
| Capital expenditure | $m | [21.3 d](/filings/0001535527-24-000026.md) | [52.6 d](/filings/0001535527-26-000010.md) | [49.7](/filings/0001535527-25-000019.md) | [39.3 d](/filings/0001535527-25-000025.md) | [78.7 d](/filings/0001535527-25-000033.md) | [87.2 d](/filings/0001535527-26-000010.md) | [85.8](/filings/0001535527-26-000025.md) | [30.5 d](/filings/0001535527-26-000031.md) | [83.4 d](/filings/0001535527-25-000033.md) | [102 d](/filings/0001535527-26-000010.md) | [97.6](/filings/0001535527-26-000025.md) | [124 d](/filings/0001535527-26-000031.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001535527-26-000025.md) | [0.0 d](/filings/0001535527-26-000031.md) | not reported | not reported | [176](/filings/0001535527-26-000025.md) | [0.0 d](/filings/0001535527-26-000031.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [234](/filings/0001535527-23-000026.md) | [241](/filings/0001535527-24-000013.md) | [242](/filings/0001535527-24-000020.md) | [244](/filings/0001535527-24-000026.md) | [250](/filings/0001535527-25-000019.md) | [251](/filings/0001535527-25-000025.md) | [246](/filings/0001535527-25-000033.md) | [248](/filings/0001535527-26-000025.md) | [1,000](/filings/0001535527-26-000031.md) | [251](/filings/0001535527-25-000033.md) | [258](/filings/0001535527-26-000025.md) | [1,044](/filings/0001535527-26-000031.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,023,934,842 at 2026-08-20, from the cover of the [10-Q filed 2026-08-27](/filings/0001535527-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.